Clinical Trial

A Study Assessing Long-Term Safety and Effectiveness in Treatment Management of Atrial Fibrillation With VARIPULSE Catheter System

Study acronym: AdmIREPAS
Recruiting
View on ClinicalTrials.gov →
Summary
The purpose of this study is to evaluate the long-term safety and effectiveness of the FDA approved VARIPULSE catheter system for pulmonary vein isolation (PVI) in the treatment of participants with symptomatic paroxysmal atrial fibrillation (PAF).
Protocol Amendment History 3 changes
notable Trial sites expanded: 19 -> 22 locations 2026-07-07
notable Trial sites expanded: 12 -> 19 locations 2026-06-06
notable Trial sites expanded: 7 -> 12 locations 2026-05-12
Trial Details
NCT Number NCT07227532
Lead Sponsor Biosense Webster, Inc.
Conditions Atrial Fibrillation
Enrollment 276 participants
Start Date 2025-10-21
Primary Completion 2030-12-31 (estimated)
Study Completion 2030-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-07-31